Monopar Therapeutics
MNPR
MNPR
82 hedge funds and large institutions have $342M invested in Monopar Therapeutics in 2026 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 33 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
5% less capital invested
Capital invested by funds: $361M → $342M (-$19.3M)
Holders
82
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$10.5M | |
| 2 | +$9.25M | |
| 3 | +$7.3M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.31M |
| 5 |
VPC
Vestal Point Capital
New York
|
+$3.95M |
Top Sellers
| 1 | -$20M | |
| 2 | -$6.23M | |
| 3 | -$3.12M | |
| 4 |
Millennium Management
New York
|
-$1.43M |
| 5 |
Citigroup
New York
|
-$822K |
